Dong Han

2.7k total citations
72 papers, 1.9k citations indexed

About

Dong Han is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Biochemistry. According to data from OpenAlex, Dong Han has authored 72 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 27 papers in Pulmonary and Respiratory Medicine and 7 papers in Biochemistry. Recurrent topics in Dong Han's work include Prostate Cancer Treatment and Research (15 papers), Epigenetics and DNA Methylation (10 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). Dong Han is often cited by papers focused on Prostate Cancer Treatment and Research (15 papers), Epigenetics and DNA Methylation (10 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). Dong Han collaborates with scholars based in China, United States and Canada. Dong Han's co-authors include Manxiang Li, Shuai Gao, Changmeng Cai, Shaojun Li, Wanting Han, Housheng Hansen He, Jill A. Macoska, Stanley B. Prusiner, Yanting Zhu and James A. Mastrianni and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Dong Han

68 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dong Han China 26 895 411 249 238 217 72 1.9k
Eun Young Choi South Korea 21 660 0.7× 217 0.5× 688 2.8× 82 0.3× 212 1.0× 55 2.0k
Lucia Rossetti Lopes Brazil 25 761 0.9× 132 0.3× 575 2.3× 158 0.7× 147 0.7× 50 2.1k
Evgenia Dobrinskikh United States 24 805 0.9× 362 0.9× 353 1.4× 82 0.3× 161 0.7× 66 2.3k
Randall S. Frey United States 25 1.3k 1.4× 212 0.5× 820 3.3× 97 0.4× 272 1.3× 30 2.5k
Yiting Tang China 24 1.2k 1.4× 215 0.5× 787 3.2× 130 0.5× 147 0.7× 50 2.1k
Kathleen Jacobs United States 17 648 0.7× 123 0.3× 155 0.6× 111 0.5× 302 1.4× 41 2.1k
Yuko Tsuruta United States 28 1.3k 1.4× 271 0.7× 852 3.4× 110 0.5× 532 2.5× 50 2.8k
Jie Fan China 21 725 0.8× 263 0.6× 602 2.4× 71 0.3× 244 1.1× 57 2.1k
Diane Kepka‐Lenhart United States 19 665 0.7× 196 0.5× 729 2.9× 123 0.5× 120 0.6× 24 2.3k
Madhavi J. Rane United States 24 801 0.9× 213 0.5× 565 2.3× 125 0.5× 91 0.4× 39 1.9k

Countries citing papers authored by Dong Han

Since Specialization
Citations

This map shows the geographic impact of Dong Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong Han more than expected).

Fields of papers citing papers by Dong Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong Han. The network helps show where Dong Han may publish in the future.

Co-authorship network of co-authors of Dong Han

This figure shows the co-authorship network connecting the top 25 collaborators of Dong Han. A scholar is included among the top collaborators of Dong Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong Han. Dong Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Wanting, Nancy Patten, Susan Patalano, et al.. (2025). Heterogeneous Responses to High-Dose Testosterone in Castration-Resistant Prostate Cancer Tumors with Mixed Rb-Proficient and Rb-Deficient Cells. Molecular Cancer Therapeutics. 24(5). 772–783.
2.
Han, Dong, Mingyao Liu, Mingwei Sheng, et al.. (2025). MicroRNA-15b promotes myofascial pain syndrome by targeting NFS1 to regulate mitophagy. Free Radical Biology and Medicine. 240. 626–640.
3.
Liu, Mingyao, Dong Han, Ling Liu, et al.. (2025). S100A9 plays a role in neuropathic pain by regulating GPR153/Kcnk16 function in DRG neurons. Cellular Signalling. 136. 112101–112101.
4.
Wang, Jiabei, Yao Liu, Hongyan Zhang, et al.. (2024). HnRNPR-mediated UPF3B mRNA splicing drives hepatocellular carcinoma metastasis. Journal of Advanced Research. 68. 257–270. 6 indexed citations
5.
Zhang, Weiwei, Ruihua Cao, Zhiyi Fang, et al.. (2024). Inhibition of the RXRA-PPARα-FABP4 signaling pathway alleviates vascular cellular aging by an SGLT2 inhibitor in an atherosclerotic mice model. Science China Life Sciences. 67(12). 2678–2691. 7 indexed citations
6.
Wang, Zifeng, Jessica Petricca, Sujun Chen, et al.. (2023). SETD7 functions as a transcription repressor in prostate cancer via methylating FOXA1. Proceedings of the National Academy of Sciences. 120(33). e2220472120–e2220472120. 9 indexed citations
7.
Han, Wanting, Zifeng Wang, Dong Han, et al.. (2023). LSD1 Inhibition Disrupts Super-Enhancer–Driven Oncogenic Transcriptional Programs in Castration-Resistant Prostate Cancer. Cancer Research. 83(10). 1684–1698. 52 indexed citations
8.
Han, Wanting, Zifeng Wang, Susan Patalano, et al.. (2023). Demethylation of EHMT1/GLP Protein Reprograms Its Transcriptional Activity and Promotes Prostate Cancer Progression. Cancer Research Communications. 3(8). 1716–1730. 1 indexed citations
9.
Han, Wanting, Dong Han, Zifeng Wang, et al.. (2022). Exploiting the tumor-suppressive activity of the androgen receptor by CDK4/6 inhibition in castration-resistant prostate cancer. Molecular Therapy. 30(4). 1628–1644. 25 indexed citations
10.
Han, Wanting, Dong Han, Zifeng Wang, et al.. (2022). RB1 loss in castration-resistant prostate cancer confers vulnerability to LSD1 inhibition. Oncogene. 41(6). 852–864. 26 indexed citations
11.
Han, Dong, Susan Patalano, Shuai Gao, et al.. (2021). Susceptibility-Associated Genetic Variation in NEDD9 Contributes to Prostate Cancer Initiation and Progression. Cancer Research. 81(14). 3766–3776. 4 indexed citations
13.
Gao, Shuai, Yanfei Gao, Housheng Hansen He, et al.. (2016). Androgen Receptor Tumor Suppressor Function Is Mediated by Recruitment of Retinoblastoma Protein. Cell Reports. 17(4). 966–976. 71 indexed citations
14.
Wang, Guizuo, Dong Han, Yonghong Zhang, et al.. (2013). A novel hypothesis: up-regulation of HO-1 by activation of PPARγ inhibits HMGB1-RAGE signaling pathway and ameliorates the development of ALI/ARDS.. Europe PMC (PubMed Central). 25 indexed citations
15.
Park, Eun Hye, Chang‐Han Lee, Ran Namgung, et al.. (2001). A Case of Hemolytic Disease in the Newborn Due to Anti-Dia Antibody.. Journal of the Korean Society of Neonatology. 8(1). 141–144. 6 indexed citations
16.
Chang, Hye Young, Eun Hye Park, Min Soo Park, et al.. (2001). Changes in Pulmonary Interleukin-6 and Pulmonary Pathology in Neonatal Mice After Exposure to Hyperoxia and Ascorbate Treatment.. Journal of the Korean Society of Neonatology. 8(1). 103–109. 1 indexed citations
17.
Lee, Eun Hee, et al.. (2001). A Study on Noninvasive Measurement of Blood Pressure in Normal Newborn.. 32(9). 1216–1223. 1 indexed citations
18.
Lee, Chul, Min Soo Park, Moon Sung Park, et al.. (1997). Physical and Biological Activity of Domestic Product of Modified Bovine Lung Surfactant. 40(6). 771–785. 2 indexed citations
19.
Park, Kook In, et al.. (1993). A Case of Cerebrocostomandibular Syndrome with Congenital Heart Disease. Korean Journal of Pediatrics. 36(4). 574–578. 1 indexed citations
20.
Lee, Chul, et al.. (1984). A Clinical Observation of Meconium Aspiration Syndrome.. 27(10). 958–964. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026